in 1924 (12) described this organism isolated from dental plaque, and Abercombie and Scott in 1928 (1) reported this organism in a single case of infective endocarditis. Even though the organism could be differentiated from the other streptococci, textbooks and taxonomy manuals have not published descriptions of the organism. The seventh edition of Bergey's Manual of Determinative Bacteriology ( 7 ) does not have a description of S. mutans. This report describes a physiological identification scheme and a comparison of physiological characteristics of s. mutans isolated from human dental plaque and blood.
MATERIALS AND METHODS
Stock strains of S. mutans were obtained from the various investigators listed in Table 1 . The human plaque isolates were kindly supplied by L. A.
Thomson, National Institute of Dental Research, Bethesda, Md. The human blood isolates were submitted to the Center for Disease Control (CDC) by various state and city health departments or by private investigators with whom we have collaborative studies. The procedures for serological grouping, determining hemolytic and catalase activities, and testing for the majority of physiological reactions listed in Table 2 have been previously described (18, 19) . Tests that have not been previously described are tolerance to 2 and 4% NaCl broths and determination of hydrolysis of hippurate. The 2 and 4% broths of NaCl were prepared by adding NaCl to heart infusion broth (Difco) up to the desired concentration. Dextrose (0.1%) and an indicator (bromocresol purple) were added to the media. The medium for determining hippurate hydrolysis was prepared by adding sodium hippurate (1% final concentration) to heart infusion broth. The three media were tubed in 16 by 125 mm screw-capped tubes and sterilized by autoclaving. Tolerance to 2 and 4% NaCl broth was determined by rotating the tubes in front of an incandescent lamp and observing for growth after 24, 48, and 72 h.
Hydrolysis of hippurate was determined by pipetting 0.8 ml of supernatant from a 48-h growth of hippurate broth to a Kahn tube; 0.2 ml of ferric chloride solution (12 g of FeC1, -6H,O in 100 ml of acqueous HC1) was added to the supernatant. A heavy precipitate that remained longer than 15 min indicated that hippurate had been split. An immediate clearing or no precipitate indicated that hippurate was not split.
Extracellular polysaccharide production (presumably glucan) was determined by the following methods:
(i) Five percent sucrose agar. Glucan production typical of S. sanguis and S. mutans resulted in highly refractile, adherent or whitedry, adherent growth on the agar. Levan production, typical of S. salivarius, resulted in opaque, gummy, nonadherent growth.
Typical S. bovis growth was similar to the growth of S, salivarius but somewhat less gummy and rarely adherent to the medium. Large or small colonies that were mucoidal and nonadherent were considered as being negative or having no extracellular polysaccharide production.
(ii) Five percent sucrose broth. Glucan production was indicated when the broth was partially or completely gelled, typical of S. sanguis. Glucan production was also indicated when gelatinous, adherent deposits formed on the bottom and walls of the growth tube, typical of S. mutans. An increase in viscosity of the broth indicated the production of slime (unknown polysaccharide) typical of S. bovis.
Negative reactions occurred when no gelling, deposits, or increase in viscosity occurred.
Facklam
INT. J. SYST. BACTERIOL. Table 1 shows the biotypes of the stock strains tested. A typical S. mutans will grow in 2% NaCl broth, form acid in litmus milk, and form acid in the following 1% carbohydrate broths: trehalose, mannitol, sucrose, inulin, lactose, sorbitol, esculin, and raffinose. Typical strains will not grow in 0.1% methylene blue milk or at 10 C. Typical strains do not hydrolyze starch, hippurate, or gelatin nor do they form acid in 1% broths of glycerol or arabinose. The majority of strains, but not all, do not grow in broth containing 6.5% NaC1. Nearly all the typical strains form extracellular polysaccharides (glucans) in either 5% sucrose agar or 5% sucrose broth or in both. The exceptional physiological reactions which make up the biotypes described are listed in Table 1 . The majority of these exceptions involve only three reactions: failure to split esculin and failure to form acid in sorbitol and in raffinose broths. Table 2 shows the percentage of strains exhibiting the different hemolytic reactions in 5% rabbit blood agar. The source of the specimen seemed to affect the kind of hemolysis observed, More blood isolates were nonhemolytic (74%) than were plaque isolates (38%), and more of the plaque isolates gave alpha reactions (54%) than did blood isolates (7%). The percentage of stock strains and the total percentages of all isolates that produce the three kinds of hemolysis were similar to those reported by Edwardsson (1 7) .
RESULTS
The results of reacting Lancefield extracts of the S. mutans strains with CDC streptococcal grouping antisera are shown in Table 2 . The majority of strains (89%) failed to react with any of the antisera. These antisera are standard Lancefield grouping antisera produced with Lancefield group A (S. pyogenes), group B (S. agalactiae), etc. Three strock strains, one blood isolate, and nine plaque isolates reacted with serogroup E antisera. One blood and one plaque isolate reacted weakly with serogroup F antisera. Also, one blood isolate and one strain isolated from an endocervix (other) reacted with serogroup K antisera. All these precipitin reactions (including E) were very weak and Table 2 also shows the results of the tests used to detect extracellular polysaccharide production by S. mu tans (presumably glucan).
All but two blood isolates and two isolates from other sources formed glucan on 5% sucrose agar. One stock strain failed to produce glucan in 5% sucrose broth. This was DeStoppelaar's (1 6) nondextran-forming mutant. The two blood isolates and five of the ten plaque isolates that failed to produce glucan in 5% sucrose broth also failed to grow after 3 days of aerobic incubation. Two strains from other sources (dog bite wound and jaw exudate) failed to produce glucan in 5% sucrose broth. These two strains were the only two S. mutans strains that failed to produce glucan in both 5% sucrose broth and agar. Table 3 gives the results of 142 S. m u t a n s strains in 29 physiological tests. The source of the specimen was found to have little or no influence on the physiological test results. All or the majority of strains were able to grow in 2% NaCl broth, form acid and clot litmus milk, and form acid in trehalose, mannitol, sucrose, inulin, lactose, sorbitol, salicin, esculin, raffinose, and melibiose broths. All or nearly all of the strains failed to grow in 0.1% methylene blue milk or at 10 C. None of the strains hydrolyzed hippurate or gelatin or tolerated 0.04% tellurite. The majority of the strains did not grow in 6.5% NaCl broth and failed to hydrolyze starch. None of the strains formed acid in glycerol, arabinose, and melezitose broths. Variable reactions were observed in bile-esculin medium, growth in 4% NaCl broth, growth at 45 C, growth on 10 and 40% bile, and reduction of 0.1% tetrazolium. Table 4 shows the number of strains of S. mutans isolated from various sources that gave the biotype reactions listed in Table 1 . More than 95% of the strains did not have any exceptional reactions. Only four of 54 blood isolates and 1 1 of 50 plaque isolates deviated from the biotype I reactions. One of six isolates from other sources deviated from biotype I reactions. In general, the biochemical patterns observed were consistent with those observed b y other investigators (1 1 , 17, 22) .
DISCUSSION
At the CDC, biotyping of S. mutans is not considered to be necessary or valid. It is Streptococcal grouping antisera used were specific antisera for groups A, B, C, D, E, F, G , H, K, and 0 streptococci. All strains that failed to form dextrans were biotype I except one plaque biotype IV strain. The one stock strain that failed to produce dextran in 591 sucrose broth was DeStoppelaar's nondextran-producing mutant. The two blood isolates and five of the 10 plaque isolates that failed to produce dextrans in 5 % sucrose broth failed to grow in the medium. Two strains from other sources (dog bite wound and jaw exudate) failed to produce dextran on either the agar or broth. No other strains failed to produce dextran in both tests.
presented here as a convenient method for demonstrating atypical strains. In the description of the species, we accept the variable reactions such as splitting of esculin and acid formation in raffinose and sorbitol broths. Strains that fail to give positive reactions in one or more of these three tests, but give all the other expected reactions of S. mutans, are considered t o be S. m u t a n s strains even though they are atypical. All streptococci giving alpha and gamma reactions in blood agar are speciated by "spectrum analysis'' (18) . Spectrum analysis is observing the results of the reactions listed in Tables 2 and 3 by unknown strains; the resulting reactions fit known reactions of stock strains of streptococcal species.
The hemolytic activity and serogrouping (primarily for elimination of group D reaction) of the strains help to identify S. mutans. It is important that these characteristics be used in conjunction with the different physiological characteristics, because identification of S. Facklam INT. J. SYST. BACTERIOL. Table 2 . Not all strains were tested. mutans from S. uberis. S. uberis forms acid in the same carbohydrate broths as does S. mutans. Also, extracts of some strains of S. uberis react with streptococcal group E antisera (15) . Although S. mutans has antigenic (probable group E antigen) relationships and certain physiological (mannitol and sorbitol fermentation) similarities t o S. uberis and S. infrequens (serogroup E beta-hemolytic streptococci), it is easily differentiated from these streptococci by differences in serological, hemolytic, and physiological characteristics. Each of these are distinct, clearly definable species. Some strains of S. mutans share physiological characteristics of the group D streptococci. The tolerance to 40% bile, the bile-esculin reaction, and 6.5% NaCl tolerance are characteristics of S. faecalis and its varieties, S. faecium and S. durans. The majority of these strains grow at 10 C, tolerate 0.1% methylene blue milk, and yield serological group D reactions ( 16) . These characteristics along with other physiological differences easily differentiate (by spectrum analysis) these organisms from S. mutans. The group D species, S. bovis, shares a number of physiological characteristics with S. mutans. S. bovis is differentiated from S. mutans by obtaining serological group D reactions from extracts of S. bovis strains. Extracellular polysaccharide formation by S. bovis in 5% sucrose broth is different from that of S. mutans. S. bovis increases the viscosity of the broth but does not gel or form the gelatinous deposits in the broth. Glucan formation by S. bovis on 5% sucrose agar is usually, but not always, different from that of S. mutans. S. bovis occasionally produces adherent, highly refractile colonies on 5% sucrose agar (typical of S. mutans) but more often produces the nonadherent, opaque gumdrop colonies. Typical strains of s. bovis always hydrolyze starch, whereas S. mutans strains d o not. An occasional S. mutans strain will hydrolyze starch very weakly, unlike S. bovis which hydrolyzes starch very strongly. The colonial morphology on blood agar also helps in recognizing S. mutans. It grows poorly; a thin film of growth is barely visible after 24 h at 35 C. S. bovis grows very readily, like the enterococci; lush growth is observed at 24 h at 35 C. When examined by spectrum analysis, these organisms can be differentiated.
It is not surprising to find that S. mutans is antigenically hcterogenous. Bratthall's studies (3, 4, 5, 6) have shown five different serotypes of S. mutans, one of which is homologous to serogroup E streptococci. In view of our own studies, some strains of S. mutans may be antigenically related t o streptococci other than group E streptococci (group K and F). The deoxyribonucleic acid (DNA) homology studies of Coykendall (13, 14) also support the fact that the taxon S. mutans includes a heterologous collection of strains. Both Bratthall and Coykendall feel that their data support each other. Coykendall reported that there was more DNA homology between strains of the same Bratthall serotype and less homology between strains of different Bratthall serotypes; however, he has reported on only nine strains and has not included type "e" in his studies.
Recently, Brown and Patterson (8) This taxon is as well defined (physiologically) as many of the species of streptococci and is better defined than any of the viridans streptococci. I do not think there is any value at the present in dividing S. mutans into additional species. Recognizing the different antigenic compositions of strains should be sufficient for epidemiological studies. Investigators should use caution in the use of terminology when referring to the typing of S. mutans. It is unfortunate that the term "group" has been used by some investigators when referring to the different type antigens of S. mutans. Since the letter system (A, B, C) has been widely adopted to refer to the Lancefield system of identification, it will become confusing to have another system of naming antigens with the term "group" and letters used for identifying antigens among the streptococci. Typing species of streptococci is clear and convenient when arabic or roman numerals are used to designate sub t y p es.
The antibiotic susceptibilities of S. mutans isolated from documented cases of subacute bacterial endocarditis are quite uniform (C. Thornsberry, C. N. Baker, and R. R. Facklam, Prog. Abstr. Intersci. Conf. Antimicrob. Ag. Chemother., 13th, Washington, D.C., Abstr. 209, 1973 ). The organism is highly susceptible to penicillin and patients are cured of S. mutans subacute bacterial endocarditis quite successfully with penicillin therapy (unpublished data). Thus, there is no medical reason to subdivide the species. It is felt that s. mutans is a clearly definable species and can be recognized by its physiological characteristics. The failure of Lancefield extracts of S. mutans to react with streptococcal group D antisera, the formation of characteristic gelatinous deposits in 5% sucrose broth, and acid formation in mannitol broth are major criteria for recognizing S.
mutans.
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